Study of Efficacy of the MyoTrain System in a Population of Individuals With Trans-radial Limb Loss
Part of paid clinical trials in Grand Rapids, Michigan.
- Sponsor
- Infinite Biomedical Technologies
- Study ID
- NCT05888428
- Status
- Recruiting
Conditions
- Amputation
- Upper Limb
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- MyoTrain — DEVICEMyoTrain is a virtual prosthesis control training system. From a hardware perspective it consists of an Apple iPad tablet computer and an eight-channel EMG armband, based on the Element electrode platform, which interfaces with the tablet via Bluetooth™. From a software perspective, MyoTrain was developed in the cross-platform Unity 4.0 game development environment.
- Motor Imagery — BEHAVIORALMotor imagery describes the process by which a prosthesis user mentally simulates the execution of a desired limb movement and activates the musculature of the residual limb that would generate the desired movement.
Study Details
The investigators propose to evaluate the efficacy of MyoTrain in a prospective clinical study involving 16 individuals with trans-radial upper-limb loss over a period of 206 days. These individuals will be randomized to Group A (Control Group using standard motor imagery training) and Group B (who are provided the MyoTrain system). The investigators will test three hypotheses: 1. The use of MyoTrain results in skills transference to control of the final prosthesis 2. The virtual outcome measures in MyoTrain are correlated with real-world functional outcome measures 3. The use of MyoTrain results in improved clinical outcomes as measured by functional, subjective and usage metrics Following a baseline functional assessment, participants will undergo a 30-day pre-prosthetic training period specific to their assigned Group. After this training period, participants will receive their prosthetic device and occupational therapy consistent with the current clinical care standard, after which they will again undergo clinical assessment. Post-device delivery, participants will then complete 3 56-day blocks of at-home prosthesis use, in between which they will return to clinic for assessment.
Key Dates
- Start date
- Feb 2, 2024
- Status verified
- Oct 2025
- Primary completion
- Aug 31, 2026
- Completion
- Aug 31, 2026
Study Design
- Enrollment
- 16 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: ExperimentalParticipants will be provided with the take-home MyoTrain system, which includes the MyoTrain armband, iPad, and MyoTrain software. Participants will progress through the training modules of the MyoTrain software, starting with eliciting paired single DoF antagonistic movements and ending with the proportional control of complex, 2-DoF hand and wrist movements.
- Active Comparator: ControlParticipants will be provided motor imagery exercises that involve brief attempts to move the missing limb in a similar manner to how they would control their pattern recognition system to strengthen their muscles. These exercises do not involve any real-time control feedback.
Primary Outcome Measure
Mean Prosthesis Wear Duration [ Time Frame: Days 35-206 ]
Central Contacts
- Rahul R Kaliki443-451-7175
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Hanger Clinic - Grand Rapids | Grand Rapids | Michigan | 49546 |
Find similar trials in Grand Rapids, MI
Related Studies
- Short-term Implanted Electrodes Following Regenerative Peripheral Nerve Surgery for Improving Prosthetic Limb Control SignalsRecruiting · University of Michigan · Ann Arbor, Michigan
- Controlling Locomotion Over Continuously Varying Activities for Agile Powered Prosthetic LegsRecruiting · University of Michigan · Ann Arbor, Michigan
- Regenerative Peripheral Nerve Interface for Control of Lower Limb ProsthesesRecruiting · University of Michigan · Ann Arbor, Michigan
- Human Penile AllotransplantationPHASE2/PHASE3 · Recruiting · Johns Hopkins University · Baltimore, Maryland